Corporate Venture Capital

Biography

Colin is a Principal with Cerity Partners Ventures’ team in Boston.  He focuses on early- and growth-stage investments in biotechnology, digital health, and pharmaceutical manufacturing.

Prior to joining Cerity Partners, Colin was a Senior Associate at Touchdown Ventures, a pioneer of the “venture capital as a service” model that merged with Cerity Partners in 2024. Colin joined Touchdown after completing his residency in emergency medicine at Harvard (MGH/BWH), during which he worked with the venture investment teams at RA Capital and Valtruis. He has also held positions at multiple hospital systems in operations and growth strategy, and he has a research background in cellular biology. 

Education

  • MD from the Geisel School of Medicine at Dartmouth
  • MBA from the Tuck School of Business at Dartmouth
  • BA in Biochemistry (minor in Mathematics) from Connecticut College

Highlights

  • Board certified physician in Emergency Medicine
  • Observes board meetings for multiple healthcare startups, including Syntis Bio and Mend Nutrition
  • 5 peer reviewed publications, 10+ academic lectures

Request an Introduction to Colin Tasi

By clicking “Submit”, you acknowledge that we collect your name, email address and phone number to respond to your inquiries and provide you information about our products and services in accordance with our Privacy Policy. If you are a California resident, please see our CCPA Notice to California Residents.

Meet Our Corporate Venture Capital Colleagues